These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1670060)

  • 1. Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus.
    Colin-Jones DG; Langman MJ; Lawson DH; Logan RF; Paterson KR; Vessey MP
    Q J Med; 1991 Jan; 78(285):13-9. PubMed ID: 1670060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
    Chandanos E; Lindblad M; Jia C; Rubio CA; Ye W; Lagergren J
    Br J Cancer; 2006 Jul; 95(1):118-22. PubMed ID: 16755290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma.
    Ye W; Chow WH; Lagergren J; Boffetta P; Boman G; Adami HO; Nyrén O
    Br J Cancer; 2001 Nov; 85(9):1317-21. PubMed ID: 11720467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence and pathologic distribution of esophageal cancers at the gastro-esophageal junction between 1993-2003].
    Lakatos PL; Lakatos L; Fuszek P; Lukovich P; Kupcsulik P; Halbász J; Schaff Z; Papp J
    Orv Hetil; 2005 Feb; 146(9):411-6. PubMed ID: 15830608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986-1997.
    Orengo MA; Casella C; Fontana V; Filiberti R; Conio M; Rosso S; Tumino R; Crosignani P; De Lisi V; Falcini F; Vercelli M;
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):739-46. PubMed ID: 16772831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity.
    Ryan AM; Rowley SP; Fitzgerald AP; Ravi N; Reynolds JV
    Eur J Cancer; 2006 May; 42(8):1151-8. PubMed ID: 16630714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 101 oesophageal cancers: a surgeon uses radiotherapy.
    Earlam RJ; Johnson L
    Ann R Coll Surg Engl; 1990 Jan; 72(1):32-40. PubMed ID: 1689132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences.
    Falk J; Carstens H; Lundell L; Albertsson M
    Acta Oncol; 2007; 46(8):1070-4. PubMed ID: 17851842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.
    Vaughan TL; Davis S; Kristal A; Thomas DB
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):85-92. PubMed ID: 7742727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
    Nagel G; Linseisen J; Boshuizen HC; Pera G; Del Giudice G; Westert GP; Bueno-de-Mesquita HB; Allen NE; Key TJ; Numans ME; Peeters PH; Sieri S; Siman H; Berglund G; Hallmans G; Stenling R; Martinez C; Arriola L; Barricarte A; Chirlaque MD; Quiros JR; Vineis P; Masala G; Palli D; Panico S; Tumino R; Bingham S; Boeing H; Bergmann MM; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Olsen A; Tjonneland A; Trichopoulou A; Bamia C; Soukara S; Sabourin JC; Carneiro F; Slimani N; Jenab M; Norat T; Riboli E; González CA
    Int J Epidemiol; 2007 Feb; 36(1):66-76. PubMed ID: 17227779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.
    Suleiman UL; Harrison M; Britton A; McPherson K; Bates T
    Eur J Cancer Prev; 2000 Jun; 9(3):185-91. PubMed ID: 10954258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications.
    Weiss MM; Kuipers EJ; Hermsen MA; van Grieken NC; Offerhaus J; Baak JP; Meuwissen SG; Meijer GA
    J Pathol; 2003 Feb; 199(2):157-65. PubMed ID: 12533828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997.
    Walther C; Zilling T; Perfekt R; Möller T
    Eur J Surg; 2001 Oct; 167(10):748-57. PubMed ID: 11775726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
    Cooper BT; Chapman W; Neumann CS; Gearty JC
    Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
    Duan L; Wu AH; Sullivan-Halley J; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):526-33. PubMed ID: 19190141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group.
    Wijnhoven BP; Siersema PD; Hop WC; van Dekken H; Tilanus HW
    Br J Surg; 1999 Apr; 86(4):529-35. PubMed ID: 10215831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden.
    Sundelöf M; Lagergren J; Ye W
    Eur J Cancer; 2008 Jul; 44(11):1566-71. PubMed ID: 18434132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.